Other
Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
Abstract
No AccessJournal of UrologyUrological Survey1 Jan 2020Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer Samir S. TanejaMD Samir S. TanejaSamir S. Taneja More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000611504.41578.eeAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Re: Enzalutamide with Standard...
Paper Details
Title
Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
Published Date
Jan 1, 2020
Journal
Volume
203
Issue
1
Pages
32 - 33
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History